Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rose Geranium in Sesame Oil Nasal Spray for Nasal Vestibulitis in Cancer Patients
NCT04620369Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nasal vestibulitis (2 arms), sponsored by Mayo Clinic. Primary endpoint: Response at 2 weeks. Started Nov 2020; status: completed.
02
Conditions
nasal vestibulitis
Beyond the preview
Go deeper on NCT04620369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04620369.